For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.

Date published: December 2010
Denosumab is a new medicine for women with osteoporosis. It is given as an injection once every 6 months.
Denosumab prevents broken bones in women with osteoporosis. It’s not known if denosumab is better at preventing broken bones than other osteoporosis medicines.
Like all treatments for osteoporosis, denosumab has some common side effects. But it’s a new medicine, so not all of its long-term side effects are known.
Some women may prefer a denosumab injection to taking tablets. You will still need to take calcium and vitamin D if these have been prescribed for you.
1. What denosumab is
2. What denosumab is for
3. Who can use denosumab
4. How to use denosumab
5. What does denosumab do?
6. Important side effects to consider
7. What else you should know about denosumab
8. Other medicines available for osteoporosis
9. How to decide between denosumab and other medicines
10. What does denosumab cost?
11. Other ways to help osteoporosis
12. Where to find more information
The active ingredient is the chemical in the medicine that makes the medicine work. Many medicines are known by their brand names as well as by the name of the active ingredient. Some medicines are available under several different brand names.
The active ingredient of this medicine is denosumab (pronounced den-os-u-mab).
It is also known by the brand name Prolia.
Denosumab is given as an injection under the skin.
It is a type of medicine called an anti-resorptive. This means that it slows bone loss (thinning of the bones). Denosumab works in a completely different way from other anti-resorptive medicines.
Your doctor or nurse might refer to a broken bone as a fracture.
Denosumab is used to treat osteoporosis in women who have passed the menopause (postmenopausal women).
Osteoporosis is a condition in which cells in the bone break down faster than new ones can replace them. This causes a gradual loss of bone tissue and makes your bones brittle and prone to breaking easily.
Your doctor will ask you to have a bone mineral density scan if they think you have osteoporosis.
A bone mineral density scan, sometimes called a DEXA scan, measures the density of your bones. It compares your result to the bone density of an average young adult. It is quick and painless, like an x-ray.
The result of your bone mineral density scan is called a T-score. If you have osteoporosis, your T-score will be minus 2.5 or lower. The lower your T-score, the more likely you are to break a bone in your hip, spine or wrist. For example, a T-score of minus 3 means that your bones are more brittle — and prone to breaking — than someone with a score of minus 2.5.
Talk with your doctor about all the treatment options for postmenopausal osteoporosis.
You can use denosumab if you have been diagnosed with postmenopausal osteoporosis.
It is available through the Pharmaceutical Benefits Scheme (PBS) for:
or
Denosumab is given as an injection under the skin of your thigh, abdomen, or back of your arm. The injection is given once every 6 months.
Your doctor or nurse can give you the injection. You, or a carer, might be able to give the injection, but some training would be needed first.
A clinical trial is a research study conducted with patients, which compares one treatment with one or more other treatments, or with no other treatment, to assess its effectiveness and safety.
In clinical trials, denosumab slowed the breakdown of bone cells and increased bone mineral density.
In another trial, women were less likely to break a bone if they received denosumab rather than a placebo (dummy medicine).
It’s not known if denosumab is any better at preventing broken bones than other medicines for osteoporosis.
All medicines can have side effects. Sometimes, the side effects are serious but most of the time they are not. Some side effects are common, while others are very rare.
The terms common, uncommon and rare are used to describe the chance of getting a side effect. This is what they mean:
common – up to 1 in 10 people may get this side effect.
uncommon – up to 1 in 100 people.
rare – up to 1 in 1,000 people.
For a list of possible side effects, see the consumer medicine information (CMI) leaflet for denosumab, available on the NPS website.
You can also discuss side effects with a pharmacist by calling the Adverse Medicines Event (AME) Line on 1300 134 237 (Mon–Fri, 9am–5pm).
Rash and itchy, dry and scaly skin are common side effects of denosumab treatment. They can affect the skin around the injection site, but often appear elsewhere. These side effects may clear up on their own, or they may need to be treated by your doctor.
Some women might get a serious skin infection (called cellulitis) caused by bacteria. It’s uncommon, but may need to be treated in hospital.
Denosumab may lower the calcium levels in your blood. This is a rare side effect. Most people will not have any symptoms, but you should contact your doctor right away if you have cramps in your muscles or numbness in your fingers or toes.
Denosumab may cause problems with your immune system or pancreas, but this hasn’t been confirmed. The answer will only become clear when denosumab has been used by many more women. But in the meantime, you should tell your doctor if you have any of the following symptoms:
Rarely, denosumab — and some other medicines for osteoporosis — can cause pain and weakening of bones in the jaw. You can reduce the chance of this happening by taking good care of your teeth and telling your dentist that you are using denosumab.
Low levels of calcium in the blood can be a problem for people using denosumab. Your doctor may perform a blood test to check your calcium level before prescribing denosumab.
Most people taking medicines for osteoporosis need to take a calcium supplement as well. Your doctor may also recommend a vitamin D supplement.
Talk with your doctor about all the treatment options for osteoporosis.
Medicine Updates are available for alendronate, zoledronic acid and strontium.
Like denosumab, most other medicines for osteoporosis work by slowing bone loss. They are called anti-resorptives, but they work in different ways.
The anti-resorptives are:
Another osteoporosis medicine — teriparatide — works by increasing bone formation.
All of the osteoporosis medicines listed above are available on the PBS. But they are prescribed in different ways and for different people.
Your doctor will be able to tell you which osteoporosis medicines are available to you through the PBS.
Alendronate (brand names Fosamax, Adronat, Alendrobell and Ossmax), etidronate (Didrocal) and risedronate (Actonel) are tablets. Some are taken daily, while others can be taken weekly or monthly.
Zoledronic acid (Aclasta) is given as a drip into a vein in the arm (called an intravenous infusion) once a year.
Raloxifene (Evista) is a tablet that prevents bone loss in a similar way to the hormone oestrogen. It can only be prescribed through the PBS if you have had a bone break due to osteoporosis.
Strontium (Protos) comes as a powder that you dissolve in water. It is taken once a day at bedtime, at least two hours after eating or drinking milk.
Teriparatide (Forteo) is used by people who have severe osteoporosis. It’s given as an injection once a day into the thigh or abdomen.
Teriparatide can only be prescribed through the PBS if you have had 2 or more broken bones caused by osteoporosis.
Women who have already broken a bone are more likely to break another bone, so they may benefit most from using medicines for osteoporosis.
A medicine that suits one person may not suit another. You might want to avoid certain side effects or, if the medicine is working well, you may be willing to put up with the possible side effects.
Making a choice between medicines for osteoporosis can be difficult. There are some important questions to ask:
Think about what matters most to you, and discuss your preferences with your doctor.
Some osteoporosis medicines can be difficult to take. You might have to sit upright after you’ve swallowed the tablet (to avoid stomach problems), or remember to take your medicine once each week or month. Denosumab could be an alternative because it’s given as an injection under the skin once every 6 months.
Zoledronic acid is also an injection. It’s given as a drip into a vein once a year. You can read more about zoledronic acid here.
Denosumab has not been used to treat osteoporosis for very long, so there is less experience with it than other osteoporosis treatments.
It has some common side effects that can affect your skin, but denosumab will need to be used by many more women before doctors and pharmacists know all of its possible side effects.
Most medicines prescribed by your doctor are covered by the PBS. This means that the Australian Government pays part of the cost of your medicine.
You will need to pay the full price if the medicine is not available on the PBS, or is not available on the PBS for your specific condition.
For more information see www.pbs.gov.au.
The full cost of denosumab to the Australian Government is:
Each prescription is for a single denosumab injection once every 6 months.
If you get denosumab through the Pharmaceutical Benefits Scheme (PBS), the Australian Government pays most of the cost and you will pay only a part, called the co-payment.
At the time of publication, the co-payment for people who are entitled to get denosumab through the PBS is:
If you're not eligible to get denosumab through the PBS, you will need to pay the full price for a prescription.
A healthy lifestyle — regular exercise, calcium in the diet, some sunshine and no smoking — is important to help prevent osteoporosis worsening and to manage it.
Exercises for osteoporosis can improve fitness, strength and balance. They can also help to prevent broken bones.
Examples include brisk walking, tai chi, dancing, aqua aerobics and gentle lifting of weights. Recommendations may differ from person to person, so you should talk to your doctor or a physiotherapist about exercises that suit you.
Avoid exercises that involve twisting, sudden severe movements or bending forward from the spine.These are not suitable if you have osteoporosis.
About 3–4 serves of dairy products each day are recommended.
One serve is:
Canned fish, tofu, soy beans, other beans and green leafy vegetables such as broccoli and bok choy also contain good amounts of calcium. If you can’t get enough calcium in your diet, then you may need to take a supplement as well.
Vitamin D is also important as it helps the body to absorb calcium. You can get this from short periods in the sun, but take measures to protect your skin between 10am and 3pm. Ask your doctor about how to get enough sunshine safely.
People who get little or no sunlight need a vitamin D supplement.
Vitamin D is also found in oily fish (such as tuna or mackerel), eggs and liver, and is added to some milks and margarines.
Smoking can cause the gradual loss of bone tissue – quitting is extremely important, and not just for your bones. Call the Quitline on 131 848 if you want help.
Reducing your chance of falling again may help you to prevent fractures. Your GP, physiotherapist or occupational therapist can help you work out your risk of falling and advise you about what you can do to keep yourself safe.
You can get the CMI leaflet for Prolia from:
NPS works with healthdirect Australia to provide consumers with information on medicines.
To get information about denosumab call 1300 MEDICINE (1300 633 424) from anywhere in Australia for the cost of a local call (excluding mobiles).
Service is available Monday–Friday, 9am–5pm EST except NSW public holidays.
Call the Adverse Medicine Events (AME) Line on 1300 134 237 (Mon–Fri, 9am–5pm EST).
The AME Line lets you report and discuss side effects that might be related to your medicine. The side effects of your medicine — but not your personal details — are reported to the Australian medicines regulatory agency (the Therapeutic Goods Administration or TGA for short). The information helps to improve the safe use of medicines.
See AME Line for more information.
More information on understanding side effects is available from www.asmi.com.au.
Date published: 2010-12-16 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.